Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto de Investigación Clínica Imbanaco is a leading clinical research center located within the Centro Médico Imbanaco in Cali, Colombia. As a specialized unit of the Quirónsalud group, the institute conducts Phase I through IV clinical trials across a broad spectrum of therapeutic areas, including oncology, cardiology, and infectious diseases. It provides comprehensive research services to global pharmaceutical companies and contract research organizations, utilizing advanced hospital infrastructure and a diverse patient population. The institute is recognized for its strict adherence to international Good Clinical Practice (GCP) standards and is one of the few centers in the region certified for early-phase studies. Its integration within a high-complexity hospital allows for seamless coordination of complex clinical protocols and high-quality data collection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto de Investigación Clínica Imbanaco.